Emcure Pharmaceuticals Limited
Share Price Target & Analysis
NSE:EMCURE
VWAP
Open
Close
High
Low
52 Week High
-27.20 (-1.41%)
EMCURE
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: EMCURE Share Price Financial Analysis & Valuation
Emcure Pharmaceuticals Limited (EMCURE) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals & Drugs vertical.
It is one of Mid Cap company with Market Capitalization of Rs 0 (in Cr). Total number of free float shares are 0 (in Lacs).
Emcure Pharmaceuticals Limited is listed on NSE with Exchange ID - INE168P01015 and trading code is NSE:EMCURE with short name Emcure Pharmace.
In the past 1 year, Emcure Pharmaceuticals Limited has declared an equity dividend of Rs 0.19 per share. At the current share price of EMCURE at Rs 1898.60, this results in a dividend yield of 0.01 %.
As per the Fundamental Analysis of NSE:EMCURE, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine EMCURE underlying value and future prospects. All of this data is available in EMCURE financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:EMCURE, it is clearly understood that EMCURE is Economical performer in terms of earnings and profit margins with an EPS of 51.69. NSE:EMCURE book value per share as of today is 206.16. The current price to book ratio for EMCURE as of Sep 09, 2026 is 9.21.
Valuation of the Stock: The current valuation of EMCURE stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of EMCURE whether to BUY this stock at current valuation. The delivery percentage of EMCURE is 42906% is very crucial parameter which shows that 42906% investors are anticipating that the price of EMCURE share should go up with VWAP at 1918.45.
Now, the main question is whether to BUY or SELL, NSE:EMCURE at current valuation.
As per latest Analysis No. #865:-
⇑ STRONG BUY EMCURE if All Greens
⇗ BUY EMCURE (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD EMCURE (With Stop Loss) if only 1 Green
⇘ SELL EMCURE if NO Green Indicator
NSE: EMCURE Share Price Today (Sep 09, 2026)
(Emcure Pharmaceuticals Limited Daily Analysis on the basis of EMCURE Intraday Graph & Trend)
Emcure Pharmaceuticals Limited share price moved Down by -1.41% from its previous close of Rs 1925.8. EMCURE stock last traded price is 1898.60. EMCURE share price trend is Down with a total of 28710 stocks traded till now. It has touched an intraday high of Rs 1938.9 and an intraday low of Rs 1898. The EMCURE trading at 1898.60, Down by Rs. -27.20, or -1.41 percent which suggests that most of the Traders are anticipating that the price of EMCURE share should go Down.
NSE: EMCURE Share Price Tomorrow Prediction
(Emcure Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of EMCURE)
Emcure Pharmaceuticals Limited share price moved Down by -1.41%. EMCURE share price short term trend is Down. It suggests that EMCURE Share Price for Tomorrow remains the same with VWAP at 1918.45 will be treated as stop loss for intraday traders. Emcure Pharmaceuticals Limited Long term investors can follow the EMCURE long term trend as mentiond in future forecast table.
NSE Code |
NSE: EMCURE |
EMCURE Share Price Today |
1898.60 |
EMCURE Share Price Target Prediction for 2026 ^ |
1590 - 2058.1 |
EMCURE Share Price Target Prediction for 2027*^ |
2058.1 - 2192.6 |
EMCURE Share Price Target Prediction for 2028*^ |
2192.6 - 2346.1 |
EMCURE Share Price Target Prediction for 2029*^ |
2463 |
EMCURE Share Price Target Prediction for 2030*^ |
2534 |
EMCURE Share Price Target Prediction for 2035*^ |
2762 |
| EMCURE Current Book Value |
205.1 |
*Emcure Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^EMCURE share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
EMCURE Technical Analysis
Candlestick Pattern: @1845.9| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 1862.26 | SELL | 1858.48 | SELL |
| MA_12 | 1871.38 | SELL | 1877.51 | SELL |
| MA_20 | 1910.76 | SELL | 1885.87 | SELL |
| MA_32 | 1904.88 | SELL | 1881.55 | SELL |
| MA_50 | 1880.4 | SELL | 1862.38 | SELL |
| MA_100 | 1805.25 | BUY | 1803.42 | BUY |
| MA_200 | 1624.62 | BUY | 1669.13 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 1910.76 | Downtrend |
| MACD | -10.58 | SELL |
| ADX | 18 | NO or Weak Trend |
| DMI (+/-) | 16.85 / 18.47 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 41.56 | Neutral |
| STOCHASTIC_K (Fast) | 26.02 | Neutral |
| STOCHASTIC_D (Slow) | 42.52 | Neutral |
| CCI | -74.91 | Neutral |
| PSAR | 1920.68 | SELL |
| TRUE RANGE | 50 | SELL |
| ATR | 50.03 | SELL |
| WILLIAMS R | -91.68 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 37.7 | Neutral |
| MOMENTUM | -123.8 | SELL |
| Duration | Value |
|---|---|
| 1 Year | 25.69% |
| 3 Months | 8.25% |
| 1 Month | -6.29% |
| 1 Week | -0.05% |
| Action | Overall (%) |
|---|---|
| BUY | 13% |
| NEUTRAL / HOLD | 23% |
| SELL | 63% |
Most popular Questions & Answers about EMCURE (/ FAQ EMCURE)
Emcure Pharmaceuticals Limited stock last traded price is 1898.60. EMCURE share price moved Down by -1.41% from its previous close of Rs 1925.8.
Emcure Pharmaceuticals Limited share price trend is Down with a total of 28710 stocks traded till now. It has touched an intraday high of Rs 2068.48 and an intraday low of Rs 1898. The EMCURE trading at 1898.60, Down by Rs. -27.20, or -1.41 percent which suggests that most of the Traders are anticipating that the price of EMCURE share should go Down and the Stop Loss will be around 1918.45.
The market cap of Emcure Pharmaceuticals Limited is ₹0 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Emcure Pharmaceuticals Limited as of Sep 08, 2026 is 44.45.
The current price to book ratio for Emcure Pharmaceuticals Limited as of Sep 08, 2026 is 9.21.
The highest price of Emcure Pharmaceuticals Limited stock is ₹2048 in the last 52-week.
The lowest price of Emcure Pharmaceuticals Limited stock is ₹1260 in the last 52-week.
Emcure Pharmaceuticals Limited share trading at ₹1898.60, Down by Rs. -27.20, or -1.41 percent which suggests that most of the traders are anticipating that the price of EMCURE share should go Down.
In 2026, Stock price target for Emcure Pharmaceuticals Limited (EMCURE) will be around ₹1590 on downside and ₹2058.1 on upside. Emcure Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Emcure Pharmaceuticals Limited (EMCURE) will be around ₹2058.1 on downside and ₹2192.6 on upside. Emcure Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Emcure Pharmaceuticals Limited (EMCURE) will be around ₹2192.6 on downside and ₹2346.1 on upside. Emcure Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Emcure Pharmaceuticals Limited (EMCURE) will be around ₹2534 Emcure Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of EMCURE.
The price of Emcure Pharmaceuticals Limited (EMCURE) shares moved by -1.41%. The short-term trend for EMCURE share price is Down. It implies that the share price of EMCURE will stay the same tomorrow and that intraday traders should treat VWAP at 1918.45 as a stop loss. Investors with a long-term outlook can track EMCURE long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of EMCURE stock is 619.8. Compared to the current market price of 1898.60 INR, the EMCURE stock is Overvalued by 67.4%.
As per the fundamental analysis of Emcure Pharmaceuticals Limited (EMCURE), it is of Economical quality in terms of earnings and profit margins with an EPS of 51.69. Emcure Pharmaceuticals Limited book value per share as of today is 206.16. The current price to book ratio for EMCURE as of Sep 09, 2026 is 9.21.
NSE:EMCURE News & Other Useful Information about EMCURE Share Price
Peer Comparison of NSE: EMCURE
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals & Drugs
| Company | Price | EPS | BV |
|---|---|---|---|
| ZYDUSLIFE | 1136.50 | 40.96 | 238.63 |
| GLAND | 2974.90 | 89.58 | 677.38 |
| CADILAHC | 1136.50 | 40.96 | 238.63 |
| MADHAVBAUG | 151.00 | 10.03 | 61.48 |
| SUVENPHAR | 376.20 | 11.05 | 115.25 |
| ERIS | 1326.90 | 29.16 | 234.07 |
| PGHL | 5499.50 | 211.15 | 373.93 |
| SYMBIOTEC | 1112.00 | 4.53 | 105.01 |
| GLS | 1350.20 | 49.12 | 284.45 |
| SUPRIYA | 902.35 | 29.51 | 151.81 |
| SIGACHI | 35.17 | -1.7 | 12.62 |
| SAKAR | 1128.60 | 24.29 | 150.48 |
| ORTINLAB | 14.93 | 0 | 1.11 |
| WALPAR | 23.00 | 2.55 | 18.08 |
| JSLL | 507.85 | 21.7 | 42.89 |
| JFLLIFE | 9.70 | 2.27 | 12.12 |
| MANKIND | 2295.00 | 59.75 | 410.5 |
| SOTAC | 90.05 | 6.71 | 52.33 |
| REMUS | 904.00 | 23.29 | 276.4 |
| VILINBIO | 60.90 | 1.57 | 18.6 |
| SAROJA | 41.95 | 4.29 | 43 |
| VALIANTLAB | 119.83 | 1.44 | 60.62 |
| BLUEJET | 577.85 | 15.67 | 82.91 |
| ACCENTMIC | 687.00 | 20.63 | 114.84 |
| ZENITHDRUG | 48.85 | 5.83 | 43.69 |
| INNOVACAP | 1177.50 | 21.16 | 160.54 |
| ENTERO | 1855.80 | 8.88 | 387.5 |
| EMCURE | 1898.60 | 51.69 | 206.16 |
| MEDIORG | 26.50 | -1.83 | 21.18 |
| AKUMS | 747.10 | 10.26 | 157.14 |